Mark Lowdell
CSO
Other
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Inmune Bio, Inc. (INMB) | CSO | $66,350 | $1,452,236 |
| 2024 | Inmune Bio, Inc. (INMB) | CSO | — | $1,792,412 |
| 2023 | Inmune Bio, Inc. (INMB) | CSO | — | $150,237 |
| 2022 | Inmune Bio, Inc. (INMB) | CSO | — | $904,599 |
| 2021 | Inmune Bio, Inc. (INMB) | CSO | — | $149,478 |
| 2020 | Inmune Bio, Inc. (INMB) | CSO | — | $138,204 |
Earnings-call appearances
-
Inmune Bio, Inc. Q1 FY2026 Earnings Call2026-03-31
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q4 FY2025 Earnings Call2025-12-31
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q3 FY2025 Earnings Call2025-10-30
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q1 FY2025 Earnings Call2025-05-08
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q3 FY2024 Earnings Call2024-11-01
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q2 FY2024 Earnings Call2024-08-02
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q1 FY2024 Earnings Call2024-05-13
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q4 FY2023 Earnings Call2024-03-29
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q3 FY2023 Earnings Call2023-11-01
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q1 FY2023 Earnings Call2023-05-04
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q4 FY2022 Earnings Call2023-03-03
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q3 FY2022 Earnings Call2022-11-02
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q2 FY2022 Earnings Call2022-08-04
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q3 FY2021 Earnings Call2021-11-04
Inmune Bio, Inc. (INMB)
-
Inmune Bio, Inc. Q2 FY2021 Earnings Call2021-08-05
Inmune Bio, Inc. (INMB)